Aparna Raj Parikh

31PUBLICATIONS
329CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Feb 25, 2026
Phase 1 Study of Rezatapopt, a p53 Reactivator, in <i>TP53</i> Y220C-Mutated Tumors.

Ecaterina E Dumbrava, Geoffrey I Shapiro, Aparna R Parikh

|Jan 30, 2026
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors.

Nussara Pakvisal, Leontios Pappas, Bennett A Caughey

|Jan 08, 2026
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.

Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel

|Dec 09, 2025
Therapeutic Targeting of Epithelial-Mesenchymal Cellular Plasticity in Pancreatic Cancer.

Eric W Lin, Priyadarshini Pathak, Aileen O'Shea

|Sep 02, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Rishi Surana, Micaela Morgado, Ashwin Somasundaram

|Aug 01, 2025
A blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada.

Kimmie Ng, Cathy Eng, Petra Wildgoose

Pageof 6

Frequent Collaborators

6 joint publications

Ryan B Corcoran

5 joint publications

Jeffrey W Clark

5 joint publications

Samuel Klempner

4 joint publications

James M Cleary